HUTCHMED (China) Ltd (HCM)
16.75
-0.10
(-0.59%)
USD |
NASDAQ |
Nov 15, 16:00
16.75
0.00 (0.00%)
After-Hours: 18:18
HUTCHMED Total Assets (Quarterly): 1.261B for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.261B |
| June 30, 2024 | 1.261B |
| December 31, 2023 | 1.280B |
| June 30, 2023 | 1.297B |
| June 30, 2023 | 1.297B |
| December 31, 2022 | 1.029B |
| June 30, 2022 | 1.194B |
| June 30, 2022 | 1.194B |
| June 30, 2021 | 1.273B |
| June 30, 2021 | 1.273B |
| March 31, 2021 | 693.12M |
| June 30, 2020 | 525.56M |
| June 30, 2020 | 525.56M |
| June 30, 2019 | 495.21M |
| June 30, 2019 | 495.21M |
| March 31, 2019 | 539.30M |
| June 30, 2018 | 577.94M |
| June 30, 2018 | 577.94M |
| December 31, 2017 | 597.93M |
| June 30, 2017 | 344.70M |
| June 30, 2017 | 344.70M |
| Date | Value |
|---|---|
| December 31, 2016 | 342.44M |
| June 30, 2016 | 322.84M |
| June 30, 2016 | 322.84M |
| December 31, 2015 | 229.60M |
| September 30, 2015 | 220.90M |
| June 30, 2015 | 230.37M |
| June 30, 2015 | 230.37M |
| December 31, 2014 | 210.83M |
| June 30, 2014 | 218.02M |
| June 30, 2014 | 218.02M |
| December 31, 2013 | 185.67M |
| June 30, 2013 | 178.47M |
| June 30, 2013 | 178.47M |
| December 31, 2012 | 159.72M |
| June 30, 2012 | 198.95M |
| June 30, 2012 | 198.95M |
| December 31, 2011 | 194.77M |
| December 31, 2010 | 159.93M |
| June 30, 2010 | 143.64M |
| June 30, 2010 | 143.64M |
| December 31, 2009 | 127.75M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
525.56M
Minimum
Jun 2020
1.297B
Maximum
Jun 2023
1.085B
Average
1.261B
Median
Jun 2024
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 102.04B |
| AstraZeneca PLC | 104.34B |
| Sino Biopharmaceutical Ltd | 9.177B |
| Regencell Bioscience Holdings Ltd | 8.438M |
| Prenetics Global Ltd | 233.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 508.85M |
| Shareholders Equity (Quarterly) | 740.08M |
| Debt to Equity Ratio | 0.1109 |
| Current Ratio | 2.612 |
| Net Debt Paydown Yield | -0.73% |